Symbol:
Cyp2j4 (Ensembl: Cyp2j3)
Name:
cytochrome P450, family 2, subfamily j, polypeptide 4 (Ensembl:cytochrome P450, family 2, subfamily j, polypeptide 3)
RGD ID:
620007
Description:
Enables NADPH-hemoprotein reductase activity and arachidonate monooxygenase activity. Involved in several processes, including arachidonate metabolic process; negative regulation of peroxisome proliferator activated receptor signaling pathway; and regulation of biosynthetic process. Located in endoplasmic reticulum membrane. Used to study nephritis; pre-eclampsia; and ureteral obstruction. Biomarker of bacterial pneumonia and renal hypertension. Human ortholog(s) of this gene implicated in hypertension; myocardial infarction; pulmonary hypertension; renal fibrosis; and renal hypertension. Orthologous to human CYP2J2 (cytochrome P450 family 2 subfamily J member 2); PARTICIPATES IN acetylsalicylic acid pharmacodynamics pathway; antipyrine drug pathway; arachidonic acid metabolic pathway; INTERACTS WITH 1,2-dimethylhydrazine; 17beta-estradiol; 1H-pyrazole.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
CYP2J2; CYPIIJ4; cytochrome P450 2J4
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
CYP2J2 (cytochrome P450 family 2 subfamily J member 2)
HGNC
EggNOG, Ensembl, HomoloGene, OrthoDB, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Cyp2j9 (cytochrome P450, family 2, subfamily j, polypeptide 9)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
CYP2J2 (cytochrome P450 family 2 subfamily J member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
CYP2J2 (cytochrome P450 family 2 subfamily J member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
LOC110261221 (cytochrome P450 2J2-like)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
CYP2J2 (cytochrome P450 family 2 subfamily J member 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Homo sapiens (human):
CYP2J2 (cytochrome P450 family 2 subfamily J member 2)
Alliance
DIOPT (HGNC|Hieranoid|OMA|OrthoFinder|PANTHER|PhylomeDB)
Mus musculus (house mouse):
Cyp2j6 (cytochrome P450, family 2, subfamily j, polypeptide 6)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cyp2n13 (cytochrome P450, family 2, subfamily N, polypeptide 13)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cyp2p10 (cytochrome P450, family 2, subfamily P, polypeptide 10)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cyp2p7 (cytochrome P450, family 2, subfamily P, polypeptide 7)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cyp2p6 (cytochrome P450, family 2, subfamily P, polypeptide 6)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cyp2j20 (cytochrome P450, family 2, subfamily J, polypeptide 20)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cyp2ad3 (cytochrome P450, family 2, subfamily AD, polypeptide 3)
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Danio rerio (zebrafish):
cyp2ad6 (cytochrome P450, family 2, subfamily AD, polypeptide 6)
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Danio rerio (zebrafish):
cyp2p8 (cytochrome P450, family 2, subfamily P, polypeptide 8)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cyp2p9 (cytochrome P450, family 2, subfamily P, polypeptide 9)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
cyp2ad2 (cytochrome P450, family 2, subfamily AD, polypeptide 2)
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Danio rerio (zebrafish):
cyp2ae1 (cytochrome P450, family 2, subfamily AE, polypeptide 1)
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Danio rerio (zebrafish):
cyp2v1 (cytochrome P450, family 2, subfamily V, polypeptide 1)
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Drosophila melanogaster (fruit fly):
phm
Alliance
DIOPT (Ensembl Compara|Hieranoid|OMA)
Drosophila melanogaster (fruit fly):
phm
Alliance
DIOPT (Ensembl Compara|Hieranoid|OMA)
Caenorhabditis elegans (roundworm):
cyp-33A1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33C9
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33D1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33D3
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33B1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33C11
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33C4
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33C5
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33C7
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33C8
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33C1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33C2
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33E1
Alliance
DIOPT (Ensembl Compara|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-33E2
Alliance
DIOPT (Ensembl Compara|InParanoid|OMA|PANTHER|SonicParanoid)
Caenorhabditis elegans (roundworm):
cyp-34A7
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A1
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A5
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A6
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A8
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35A3
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35B1
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35B2
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A10
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A2
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-34A9
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35A5
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35A4
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35A2
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Caenorhabditis elegans (roundworm):
cyp-35C1
Alliance
DIOPT (Ensembl Compara|OMA|PANTHER)
Drosophila melanogaster (fruit fly):
Cyp305a1
Alliance
DIOPT (Ensembl Compara|Hieranoid|OMA)
Drosophila melanogaster (fruit fly):
Cyp303a1
Alliance
DIOPT (Ensembl Compara|Hieranoid|OMA)
Allele / Splice:
Cyp2j4em1Sage
Genetic Models:
WKY-Cyp2j4em1Sage /Tja
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 116,295,691 - 116,323,219 (-) NCBI GRCr8 mRatBN7.2 5 111,179,981 - 111,207,490 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 111,178,703 - 111,244,794 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 113,748,215 - 113,775,559 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 115,473,589 - 115,500,933 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 115,536,117 - 115,563,461 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 119,546,458 - 119,564,843 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 119,546,461 - 119,564,846 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 119,130,644 - 119,130,903 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Rnor_5.0 5 123,437,429 - 123,455,814 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 116,702,370 - 116,729,722 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 116,707,598 - 116,734,948 (-) NCBI Celera 5 109,770,343 - 109,797,690 (-) NCBI Celera Cytogenetic Map 5 q33 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Cyp2j4 Rat 1,1-dichloroethene decreases expression ISO Cyp2j9 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of CYP2J9 mRNA CTD PMID:26682919 Cyp2j4 Rat 1,2-dichloroethane decreases expression ISO Cyp2j9 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of CYP2J9 mRNA CTD PMID:28960355 Cyp2j4 Rat 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CYP2J4 mRNA CTD PMID:32387197 Cyp2j4 Rat 1,2-dimethylhydrazine decreases expression ISO Cyp2j9 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CYP2J9 mRNA CTD PMID:22206623 Cyp2j4 Rat 17alpha-ethynylestradiol affects expression ISO Cyp2j9 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of CYP2J9 mRNA CTD PMID:17555576 Cyp2j4 Rat 17beta-estradiol multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP2J2 mRNA CTD PMID:19619570 Cyp2j4 Rat 17beta-estradiol increases expression ISO Cyp2j9 (Mus musculus) 6480464 Estradiol results in increased expression of CYP2J9 mRNA CTD PMID:39298647 Cyp2j4 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CYP2J4 mRNA CTD PMID:32145629 Cyp2j4 Rat 17beta-estradiol increases expression ISO CYP2J2 (Homo sapiens) 6480464 Estradiol results in increased expression of CYP2J2 mRNA CTD PMID:19619570 Cyp2j4 Rat 1H-pyrazole multiple interactions EXP 6480464 pyrazole results in increased expression of and results in increased activity of CYP2J4 protein and pyrazole results in increased stability of and results in increased expression of CYP2J4 mRNA CTD PMID:10497137 Cyp2j4 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 Cyp2j4 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CYP2J2 mRNA CTD PMID:19619570 Cyp2j4 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2J4 mRNA CTD PMID:32109520 Cyp2j4 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp2j9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2J9 mRNA CTD PMID:28213091 Cyp2j4 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO CYP2J2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2J2 mRNA CTD PMID:19619570 more ... Cyp2j4 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cyp2j9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CYP2J9 mRNA CTD PMID:26377647 Cyp2j4 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cyp2j9 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP2J9 mRNA CTD PMID:16960034 and PMID:19465110 Cyp2j4 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2J4 mRNA and Tetrachlorodibenzodioxin results in decreased expression of CYP2J9 mRNA CTD PMID:16984957 more ... Cyp2j4 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of CYP2J9 mRNA CTD PMID:21346803 Cyp2j4 Rat 2,6-di-tert-butyl-4-methylphenol increases expression ISO CYP2J2 (Homo sapiens) 6480464 Butylated Hydroxytoluene results in increased expression of CYP2J2 mRNA CTD PMID:24021950 Cyp2j4 Rat 2,6-dinitrotoluene affects expression EXP 6480464 2 more ... CTD PMID:21346803 Cyp2j4 Rat 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 Cyp2j4 Rat 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 Cyp2j4 Rat 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of CYP2J4 mRNA CTD PMID:23358152 Cyp2j4 Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of CYP2J4 mRNA CTD PMID:28522335 Cyp2j4 Rat 4,4'-sulfonyldiphenol increases expression ISO Cyp2j9 (Mus musculus) 6480464 bisphenol S results in increased expression of CYP2J9 mRNA CTD PMID:33297965 Cyp2j4 Rat 4-hydroxynon-2-enal multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 [CYP2J2 protein results in increased oxidation of 4-hydroxy-2-nonenal] which results in increased chemical synthesis of 4-hydroxy-2-nonenoic acid more ... CTD PMID:21766881 Cyp2j4 Rat 5-Hydroxythalidomide increases metabolic processing ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased metabolism of 5-hydroxythalidomide CTD PMID:24350712 Cyp2j4 Rat 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of CYP2J4 mRNA CTD PMID:19483382 Cyp2j4 Rat 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of CYP2J4 mRNA CTD PMID:19483382 Cyp2j4 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of CYP2J4 mRNA CTD PMID:31881176 Cyp2j4 Rat acrylamide affects expression EXP 6480464 Acrylamide affects the expression of CYP2J4 mRNA CTD PMID:28959563 Cyp2j4 Rat Actein decreases expression EXP 6480464 actein results in decreased expression of CYP2J9 protein CTD PMID:29969672 Cyp2j4 Rat aflatoxin B1 increases response to substance ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 mRNA results in increased susceptibility to Aflatoxin B1 CTD PMID:29555536 Cyp2j4 Rat aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CYP2J4 mRNA CTD PMID:33354967 Cyp2j4 Rat all-trans-retinoic acid decreases expression ISO CYP2J2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of CYP2J2 mRNA CTD PMID:16985168 and PMID:23724009 Cyp2j4 Rat alpha-naphthoflavone decreases activity ISO CYP2J2 (Homo sapiens) 6480464 alpha-naphthoflavone results in decreased activity of CYP2J2 protein CTD PMID:12851038 Cyp2j4 Rat amiodarone increases expression ISO CYP2J2 (Homo sapiens) 6480464 Amiodarone results in increased expression of CYP2J2 mRNA CTD PMID:19774075 Cyp2j4 Rat amiodarone affects expression EXP 6480464 Amiodarone affects the expression of CYP2J4 mRNA CTD PMID:19483382 Cyp2j4 Rat amlodipine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Amlodipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP2J4 mRNA CTD PMID:16483693 Cyp2j4 Rat anandamide increases metabolic processing ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased metabolism of anandamide CTD PMID:29689453 Cyp2j4 Rat anandamide multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 cannabichromene inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] more ... CTD PMID:29689453 Cyp2j4 Rat arachidonic acid multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 Arachidonic Acid inhibits the reaction [CYP2J2 protein results in decreased methylation of Astemizole] CTD PMID:12386130 Cyp2j4 Rat arsenous acid decreases response to substance ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 Cyp2j4 Rat astemizole multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 Arachidonic Acid inhibits the reaction [CYP2J2 protein results in decreased methylation of Astemizole] and ebastine inhibits the reaction [CYP2J2 protein results in decreased methylation of Astemizole] CTD PMID:12386130 Cyp2j4 Rat astemizole increases metabolic processing ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased metabolism of Astemizole CTD PMID:17162467 Cyp2j4 Rat astemizole decreases methylation ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in decreased methylation of Astemizole CTD PMID:12386130 and PMID:15861034 Cyp2j4 Rat atrazine increases expression ISO CYP2J2 (Homo sapiens) 6480464 Atrazine results in increased expression of CYP2J2 mRNA CTD PMID:22378314 Cyp2j4 Rat Azelnidipine multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 NADP promotes the reaction [azelnidipine results in decreased activity of CYP2J2 protein] CTD PMID:30965050 Cyp2j4 Rat Azelnidipine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 azelnidipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat Azoxymethane multiple interactions ISO Cyp2j9 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2J9 mRNA CTD PMID:29950665 Cyp2j4 Rat barnidipine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 mepirodipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat benidipine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 benidipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of CYP2J4 mRNA CTD PMID:19483382 Cyp2j4 Rat benzo[a]pyrene increases expression ISO CYP2J2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CYP2J2 mRNA CTD PMID:20106945 more ... Cyp2j4 Rat benzo[a]pyrene decreases expression ISO CYP2J2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CYP2J2 mRNA CTD PMID:32234424 Cyp2j4 Rat benzo[a]pyrene increases methylation ISO Cyp2j9 (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of CYP2J9 exon and Benzo(a)pyrene results in increased methylation of CYP2J9 intron CTD PMID:27901495 Cyp2j4 Rat beta-naphthoflavone decreases expression ISO CYP2J2 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of CYP2J2 mRNA CTD PMID:32858204 Cyp2j4 Rat bezafibrate affects expression ISO CYP2J2 (Homo sapiens) 6480464 Bezafibrate affects the expression of CYP2J2 protein CTD PMID:29960002 Cyp2j4 Rat bis(2-ethylhexyl) phthalate decreases expression ISO CYP2J2 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of CYP2J2 mRNA CTD PMID:28412506 Cyp2j4 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP2J2 mRNA more ... CTD PMID:25181051 more ... Cyp2j4 Rat bisphenol A decreases methylation ISO CYP2J2 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of CYP2J2 gene CTD PMID:31601247 Cyp2j4 Rat bisphenol A decreases expression ISO Cyp2j9 (Mus musculus) 6480464 bisphenol A results in decreased expression of CYP2J9 mRNA CTD PMID:33221593 Cyp2j4 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP2J4 mRNA CTD PMID:33296240 Cyp2j4 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP2J4 mRNA CTD PMID:30903817 Cyp2j4 Rat bisphenol F decreases expression ISO Cyp2j9 (Mus musculus) 6480464 bisphenol F results in decreased expression of CYP2J9 mRNA CTD PMID:38685157 Cyp2j4 Rat butanal increases expression ISO CYP2J2 (Homo sapiens) 6480464 butyraldehyde results in increased expression of CYP2J2 mRNA CTD PMID:26079696 Cyp2j4 Rat butylated hydroxyanisole increases expression ISO CYP2J2 (Homo sapiens) 6480464 Butylated Hydroxyanisole results in increased expression of CYP2J2 mRNA CTD PMID:24021950 Cyp2j4 Rat cadmium dichloride decreases expression ISO CYP2J2 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of CYP2J2 mRNA CTD PMID:38382870 Cyp2j4 Rat Cannabichromene increases metabolic processing ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased metabolism of cannabichromene CTD PMID:29689453 Cyp2j4 Rat Cannabichromene multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 cannabichromene inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CTD PMID:29689453 Cyp2j4 Rat cannabidiol multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 Cannabidiol inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CTD PMID:29689453 Cyp2j4 Rat cannabidiol increases metabolic processing ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased metabolism of Cannabidiol CTD PMID:29689453 Cyp2j4 Rat cannabigerol increases metabolic processing ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased metabolism of cannabigerol CTD PMID:29689453 Cyp2j4 Rat cannabigerol multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 cannabigerol inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CTD PMID:29689453 Cyp2j4 Rat Cannabinol multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 Cannabinol inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CTD PMID:29689453 Cyp2j4 Rat Cannabinol increases metabolic processing ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased metabolism of Cannabinol CTD PMID:29689453 Cyp2j4 Rat carbon nanotube decreases expression ISO Cyp2j9 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Cyp2j4 Rat ciguatoxin CTX1B affects expression ISO Cyp2j9 (Mus musculus) 6480464 Ciguatoxins affects the expression of CYP2J9 mRNA CTD PMID:18353800 Cyp2j4 Rat cilnidipine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 cilnidipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat cimetidine multiple interactions ISO Cyp2j9 (Mus musculus) 6480464 Cimetidine inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein] CTD PMID:11856816 Cyp2j4 Rat clofibrate affects expression EXP 6480464 Clofibrate affects the expression of CYP2J4 mRNA CTD PMID:19483382 Cyp2j4 Rat clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CYP2J4 mRNA CTD PMID:12851107 Cyp2j4 Rat clozapine increases metabolic processing ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased metabolism of Clozapine CTD PMID:18809730 Cyp2j4 Rat cocaine increases expression ISO Cyp2j9 (Mus musculus) 6480464 Cocaine results in increased expression of CYP2J2 protein CTD PMID:11856816 Cyp2j4 Rat cocaine multiple interactions ISO Cyp2j9 (Mus musculus) 6480464 Cimetidine inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein] and Metyrapone inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein] CTD PMID:11856816 Cyp2j4 Rat copper(II) sulfate decreases expression ISO CYP2J2 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of CYP2J2 mRNA CTD PMID:19549813 Cyp2j4 Rat cyclosporin A decreases expression ISO CYP2J2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CYP2J2 mRNA CTD PMID:20106945 and PMID:25562108 Cyp2j4 Rat danazol decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Danazol results in decreased activity of CYP2J2 protein CTD PMID:29689254 and PMID:30965050 Cyp2j4 Rat Delapril hydrochloride decreases activity ISO CYP2J2 (Homo sapiens) 6480464 delapril results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat delta8-THC increases metabolic processing ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased metabolism of delta-8-tetrahydrocannabinol CTD PMID:29689453 Cyp2j4 Rat delta8-THC multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 delta-8-tetrahydrocannabinol inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CTD PMID:29689453 Cyp2j4 Rat dextran sulfate multiple interactions ISO Cyp2j9 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2J9 mRNA CTD PMID:29950665 Cyp2j4 Rat diarsenic trioxide decreases response to substance ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 Cyp2j4 Rat diethyl malate affects expression ISO Cyp2j9 (Mus musculus) 6480464 diethyl malate affects the expression of CYP2J9 mRNA CTD PMID:24814887 Cyp2j4 Rat difenoconazole decreases expression ISO Cyp2j9 (Mus musculus) 6480464 difenoconazole results in decreased expression of CYP2J9 mRNA CTD PMID:34425431 Cyp2j4 Rat doxorubicin multiple interactions ISO Cyp2j9 (Mus musculus) 6480464 CYP2J2 protein affects the reaction [Doxorubicin results in increased activity of CASP3 protein] more ... CTD PMID:19429816 Cyp2j4 Rat doxorubicin decreases expression ISO CYP2J2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of CYP2J2 mRNA CTD PMID:29803840 Cyp2j4 Rat doxorubicin decreases expression ISO Cyp2j9 (Mus musculus) 6480464 Doxorubicin results in decreased expression of CYP2J2 protein CTD PMID:19429816 Cyp2j4 Rat Ebastine increases hydroxylation ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased hydroxylation of ebastine CTD PMID:12386130 more ... Cyp2j4 Rat Ebastine multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 ebastine inhibits the reaction [CYP2J2 protein results in decreased methylation of Astemizole] CTD PMID:12386130 Cyp2j4 Rat Ebastine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 ebastine results in decreased activity of CYP2J2 protein CTD PMID:12851038 Cyp2j4 Rat efonidipine hydrochloride decreases activity ISO CYP2J2 (Homo sapiens) 6480464 efonidipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CYP2J4 mRNA CTD PMID:29391264 Cyp2j4 Rat epoxiconazole decreases expression ISO Cyp2j9 (Mus musculus) 6480464 epoxiconazole results in decreased expression of CYP2J9 mRNA CTD PMID:35436446 Cyp2j4 Rat ethanol increases expression ISO Cyp2j9 (Mus musculus) 6480464 Ethanol results in increased expression of CYP2J9 mRNA CTD PMID:30319688 Cyp2j4 Rat felodipine multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 NADP promotes the reaction [Felodipine results in decreased activity of CYP2J2 protein] CTD PMID:30965050 Cyp2j4 Rat felodipine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Felodipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat fenofibrate affects expression ISO CYP2J2 (Homo sapiens) 6480464 Fenofibrate affects the expression of CYP2J2 protein CTD PMID:29960002 Cyp2j4 Rat fluconazole decreases expression ISO Cyp2j9 (Mus musculus) 6480464 Fluconazole results in decreased expression of CYP2J9 mRNA CTD PMID:16730040 Cyp2j4 Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CYP2J4 mRNA CTD PMID:24793618 Cyp2j4 Rat gemfibrozil affects expression ISO CYP2J2 (Homo sapiens) 6480464 Gemfibrozil affects the expression of CYP2J2 protein CTD PMID:29960002 Cyp2j4 Rat glabridin multiple interactions ISO Cyp2j9 (Mus musculus) 6480464 [glabridin co-treated with Paclitaxel] results in decreased expression of CYP2J2 protein CTD PMID:37419298 Cyp2j4 Rat glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CYP2J4 mRNA CTD PMID:24136188 Cyp2j4 Rat glutathione multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 [CYP2J2 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac CTD PMID:24246759 Cyp2j4 Rat graphite affects expression EXP 6480464 Graphite affects the expression of CYP2J4 mRNA CTD PMID:29933104 Cyp2j4 Rat ketoconazole decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Ketoconazole results in decreased activity of CYP2J2 protein CTD PMID:12851038 Cyp2j4 Rat L-ethionine affects expression EXP 6480464 Ethionine affects the expression of CYP2J4 mRNA CTD PMID:19483382 Cyp2j4 Rat manidipine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 manidipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat menadione affects expression ISO Cyp2j9 (Mus musculus) 6480464 Vitamin K 3 affects the expression of CYP2J9 mRNA CTD PMID:20829426 Cyp2j4 Rat mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of CYP2J4 mRNA CTD PMID:23358152 Cyp2j4 Rat methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of CYP2J4 mRNA CTD PMID:30467583 Cyp2j4 Rat methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Nisoldipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat metyrapone multiple interactions ISO Cyp2j9 (Mus musculus) 6480464 Metyrapone inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein] CTD PMID:11856816 Cyp2j4 Rat Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CYP2J4 mRNA CTD PMID:21515302 Cyp2j4 Rat N-desmethylclozapine increases chemical synthesis ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased chemical synthesis of norclozapine CTD PMID:18809730 Cyp2j4 Rat N-methyl-N-nitrosourea decreases expression EXP 6480464 Methylnitrosourea results in decreased expression of CYP2J9 mRNA CTD PMID:17412507 Cyp2j4 Rat NADP zwitterion multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 NADP promotes the reaction [azelnidipine results in decreased activity of CYP2J2 protein] and NADP promotes the reaction [Felodipine results in decreased activity of CYP2J2 protein] CTD PMID:30965050 Cyp2j4 Rat NADP(+) multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 NADP promotes the reaction [azelnidipine results in decreased activity of CYP2J2 protein] and NADP promotes the reaction [Felodipine results in decreased activity of CYP2J2 protein] CTD PMID:30965050 Cyp2j4 Rat nicardipine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Nicardipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat nifedipine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Nifedipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat Nilvadipine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 nilvadipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat nisoldipine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Nisoldipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat nitrendipine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Nitrendipine results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of CYP2J4 mRNA CTD PMID:18417182 Cyp2j4 Rat okadaic acid decreases expression ISO CYP2J2 (Homo sapiens) 6480464 Okadaic Acid results in decreased expression of CYP2J2 mRNA CTD PMID:38832940 Cyp2j4 Rat omeprazole affects expression EXP 6480464 Omeprazole affects the expression of CYP2J4 mRNA CTD PMID:19483382 Cyp2j4 Rat oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of CYP2J4 mRNA CTD PMID:23439660 Cyp2j4 Rat ozone multiple interactions ISO Cyp2j9 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CYP2J9 mRNA CTD PMID:27106289 and PMID:34911549 Cyp2j4 Rat paclitaxel multiple interactions ISO Cyp2j9 (Mus musculus) 6480464 [glabridin co-treated with Paclitaxel] results in decreased expression of CYP2J2 protein and [rottlerin co-treated with Paclitaxel] results in decreased expression of CYP2J2 protein CTD PMID:35995259 and PMID:37419298 Cyp2j4 Rat paracetamol affects expression ISO Cyp2j9 (Mus musculus) 6480464 Acetaminophen affects the expression of CYP2J9 mRNA CTD PMID:17562736 Cyp2j4 Rat paracetamol decreases expression ISO CYP2J2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CYP2J2 mRNA CTD PMID:29067470 Cyp2j4 Rat paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CYP2J9 mRNA CTD PMID:17366322 Cyp2j4 Rat paraquat increases expression ISO Cyp2j9 (Mus musculus) 6480464 Paraquat results in increased expression of CYP2J9 mRNA CTD PMID:21371552 Cyp2j4 Rat pentanal increases expression ISO CYP2J2 (Homo sapiens) 6480464 pentanal results in increased expression of CYP2J2 mRNA CTD PMID:26079696 Cyp2j4 Rat perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of CYP2J4 mRNA CTD PMID:18692542 Cyp2j4 Rat perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP2J4 mRNA CTD PMID:16221955 and PMID:28511854 Cyp2j4 Rat perfluorooctanoic acid increases expression ISO CYP2J2 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of CYP2J2 mRNA CTD PMID:32588087 Cyp2j4 Rat piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of CYP2J4 mRNA CTD PMID:22484513 Cyp2j4 Rat pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of CYP2J4 mRNA CTD PMID:19483382 Cyp2j4 Rat pirinixic acid affects expression ISO CYP2J2 (Homo sapiens) 6480464 pirinixic acid affects the expression of CYP2J2 protein CTD PMID:29960002 Cyp2j4 Rat pirinixic acid multiple interactions ISO CYP2J2 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP2J2 mRNA CTD PMID:19710929 Cyp2j4 Rat pomalidomide increases oxidation ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased oxidation of pomalidomide CTD PMID:24350712 Cyp2j4 Rat pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of CYP2J4 mRNA CTD PMID:27225895 Cyp2j4 Rat prochloraz decreases expression ISO CYP2J2 (Homo sapiens) 6480464 prochloraz results in decreased expression of CYP2J2 mRNA CTD PMID:20035023 Cyp2j4 Rat propanal increases expression ISO CYP2J2 (Homo sapiens) 6480464 propionaldehyde results in increased expression of CYP2J2 mRNA CTD PMID:26079696 Cyp2j4 Rat propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP2J9 mRNA CTD PMID:16643972 Cyp2j4 Rat purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of CYP2J4 mRNA CTD PMID:23358152 Cyp2j4 Rat quercetin increases expression ISO CYP2J2 (Homo sapiens) 6480464 Quercetin results in increased expression of CYP2J2 mRNA CTD PMID:21632981 Cyp2j4 Rat quercetin decreases expression ISO Cyp2j9 (Mus musculus) 6480464 Quercetin results in decreased expression of CYP2J2 mRNA CTD PMID:16455785 Cyp2j4 Rat quinapril hydrochloride decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Quinapril results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat rifampicin decreases expression ISO CYP2J2 (Homo sapiens) 6480464 Rifampin results in decreased expression of CYP2J2 mRNA CTD PMID:33263786 Cyp2j4 Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of CYP2J4 mRNA CTD PMID:28374803 Cyp2j4 Rat rottlerin multiple interactions ISO Cyp2j9 (Mus musculus) 6480464 [rottlerin co-treated with Paclitaxel] results in decreased expression of CYP2J2 protein CTD PMID:35995259 Cyp2j4 Rat Salvianolic acid A decreases activity ISO CYP2J2 (Homo sapiens) 6480464 salvianolic acid A results in decreased activity of CYP2J2 protein CTD PMID:29689254 Cyp2j4 Rat Salvianolic acid C decreases activity ISO CYP2J2 (Homo sapiens) 6480464 salvianolic acid C results in decreased activity of CYP2J2 protein CTD PMID:29689254 Cyp2j4 Rat sodium arsenite increases expression ISO CYP2J2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of CYP2J2 mRNA CTD PMID:21281968 and PMID:38568856 Cyp2j4 Rat sodium arsenite decreases expression ISO CYP2J2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CYP2J2 mRNA CTD PMID:29301061 and PMID:34032870 Cyp2j4 Rat streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of CYP2J4 mRNA CTD PMID:25905778 Cyp2j4 Rat sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide and E coli O55-B5] affects the expression of CYP2J4 mRNA CTD PMID:20371263 Cyp2j4 Rat telmisartan decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Telmisartan results in decreased activity of CYP2J2 protein CTD PMID:30965050 Cyp2j4 Rat Terfenadine increases hydroxylation ISO CYP2J2 (Homo sapiens) 6480464 CYP2J2 protein results in increased hydroxylation of Terfenadine CTD PMID:24021950 Cyp2j4 Rat Terfenadine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Terfenadine analog results in decreased activity of CYP2J2 protein and Terfenadine results in decreased activity of CYP2J2 protein CTD PMID:12851038 and PMID:19289568 Cyp2j4 Rat Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CYP2J4 mRNA CTD PMID:21515302 Cyp2j4 Rat tetrachloromethane decreases expression ISO Cyp2j9 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of CYP2J9 mRNA CTD PMID:27339419 and PMID:31919559 Cyp2j4 Rat tetracycline increases expression ISO Cyp2j9 (Mus musculus) 6480464 Tetracycline results in increased expression of CYP2J9 mRNA CTD PMID:16917069 Cyp2j4 Rat tetraphene decreases expression ISO Cyp2j9 (Mus musculus) 6480464 benz(a)anthracene results in decreased expression of CYP2J9 mRNA CTD PMID:26377693 Cyp2j4 Rat thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of CYP2J4 mRNA CTD PMID:19483382 Cyp2j4 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP2J4 mRNA CTD PMID:34492290 Cyp2j4 Rat titanium dioxide multiple interactions ISO Cyp2j9 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2J9 mRNA CTD PMID:29950665 Cyp2j4 Rat tranylcypromine decreases activity ISO CYP2J2 (Homo sapiens) 6480464 Tranylcypromine results in decreased activity of CYP2J2 protein CTD PMID:12851038 Cyp2j4 Rat triadimefon increases expression ISO Cyp2j9 (Mus musculus) 6480464 triadimefon results in increased expression of CYP2J9 mRNA CTD PMID:16730040 Cyp2j4 Rat triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP2J9 mRNA CTD PMID:16643972 Cyp2j4 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CYP2J4 mRNA CTD PMID:33387578 Cyp2j4 Rat triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of CYP2J4 mRNA CTD PMID:30447264 Cyp2j4 Rat trimellitic anhydride decreases expression ISO Cyp2j9 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of CYP2J9 mRNA CTD PMID:19042947 Cyp2j4 Rat triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CYP2J4 mRNA CTD PMID:30589522 Cyp2j4 Rat troglitazone decreases activity ISO CYP2J2 (Homo sapiens) 6480464 troglitazone results in decreased activity of CYP2J2 protein CTD PMID:12851038 Cyp2j4 Rat troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP2J4 mRNA CTD PMID:21515302 Cyp2j4 Rat urethane increases expression ISO CYP2J2 (Homo sapiens) 6480464 Urethane results in increased expression of CYP2J2 mRNA CTD PMID:28818685 Cyp2j4 Rat valproic acid affects expression ISO Cyp2j9 (Mus musculus) 6480464 Valproic Acid affects the expression of CYP2J9 mRNA CTD PMID:17292431 Cyp2j4 Rat valproic acid increases expression ISO CYP2J2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of CYP2J2 mRNA CTD PMID:28001369 and PMID:29154799 Cyp2j4 Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CYP2J4 mRNA CTD PMID:23034163 Cyp2j4 Rat zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of CYP2J4 mRNA CTD PMID:27225895
Molecular Function
Only show annotations with direct experimental evidence (0 objects hidden)
Cyp2j4 Rat arachidonate 11,12-epoxygenase activity enables ISO CYP2J2 (Homo sapiens) 1624291 PMID:11901223 RGD PMID:11901223 Cyp2j4 Rat arachidonate 14,15-epoxygenase activity enables ISO CYP2J2 (Homo sapiens) 1624291 PMID:11901223 RGD PMID:11901223 Cyp2j4 Rat arachidonate epoxygenase activity enables ISO CYP2J2 (Homo sapiens) 1624291 PMID:11901223 and PMID:8631948 RGD PMID:11901223 and PMID:8631948 Cyp2j4 Rat arachidonate epoxygenase activity enables IEA UniProtKB:O54750 and ensembl:ENSMUSP00000030303 1600115 GO_REF:0000107 Ensembl GO_REF:0000107 Cyp2j4 Rat arachidonate monooxygenase activity enables IDA 632631 PMID:9143331 UniProt Cyp2j4 Rat heme binding enables IEA InterPro:IPR001128 more ... 1600115 GO_REF:0000002 InterPro GO_REF:0000002 Cyp2j4 Rat heme binding enables IBA PANTHER:PTN000670347 more ... 1600115 GO_REF:0000033 GO_Central GO_REF:0000033 Cyp2j4 Rat iron ion binding enables IEA InterPro:IPR001128 more ... 1600115 GO_REF:0000002 InterPro GO_REF:0000002 Cyp2j4 Rat isomerase activity enables ISO CYP2J2 (Homo sapiens) 1624291 PMID:19737933 RGD PMID:19737933 Cyp2j4 Rat linoleic acid epoxygenase activity enables ISO CYP2J2 (Homo sapiens) 1624291 PMID:11901223 RGD PMID:11901223 Cyp2j4 Rat metal ion binding enables IEA UniProtKB-KW:KW-0479 1600115 GO_REF:0000043 UniProt GO_REF:0000043 Cyp2j4 Rat monooxygenase activity enables IEA UniProtKB-KW:KW-0503 1600115 GO_REF:0000043 UniProt GO_REF:0000043 Cyp2j4 Rat monooxygenase activity enables IEA InterPro:IPR001128 more ... 1600115 GO_REF:0000002 InterPro GO_REF:0000002 Cyp2j4 Rat NADPH-hemoprotein reductase activity IDA 632631 RGD Cyp2j4 Rat oxidoreductase activity enables IEA UniProtKB-KW:KW-0560 1600115 GO_REF:0000043 UniProt GO_REF:0000043 Cyp2j4 Rat oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen enables IEA InterPro:IPR001128 more ... 1600115 GO_REF:0000002 InterPro GO_REF:0000002 Cyp2j4 Rat oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen enables IBA PANTHER:PTN000670347 more ... 1600115 GO_REF:0000033 GO_Central GO_REF:0000033 Cyp2j4 Rat oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen enables IEA EC:1.14.14.1 1600115 GO_REF:0000003 UniProt GO_REF:0000003 Cyp2j4 Rat oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen enables IEA InterPro:IPR008071 1600115 GO_REF:0000002 InterPro GO_REF:0000002
Imported Annotations - SMPDB
Imported Annotations - KEGG (archival)
1,1-dichloroethene (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (EXP,ISO) 17alpha-ethynylestradiol (ISO) 17beta-estradiol (EXP,ISO) 1H-pyrazole (EXP) 2,2',4,4',5,5'-hexachlorobiphenyl (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dinitrotoluene (EXP) 2,6-di-tert-butyl-4-methylphenol (ISO) 2,6-dinitrotoluene (EXP) 3,3',4,4',5-pentachlorobiphenyl (EXP) 3,7-dihydropurine-6-thione (EXP) 3-chloropropane-1,2-diol (EXP) 4,4'-sulfonyldiphenol (ISO) 4-hydroxynon-2-enal (ISO) 5-Hydroxythalidomide (ISO) 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole (EXP) 6-propyl-2-thiouracil (EXP) acetamide (EXP) acrylamide (EXP) Actein (EXP) aflatoxin B1 (EXP,ISO) all-trans-retinoic acid (ISO) alpha-naphthoflavone (ISO) amiodarone (EXP,ISO) amlodipine (ISO) ammonium chloride (EXP) anandamide (ISO) arachidonic acid (ISO) arsenous acid (ISO) astemizole (ISO) atrazine (ISO) Azelnidipine (ISO) Azoxymethane (ISO) barnidipine (ISO) benidipine (ISO) benzbromarone (EXP) benzo[a]pyrene (ISO) beta-naphthoflavone (ISO) bezafibrate (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) butanal (ISO) butylated hydroxyanisole (ISO) cadmium dichloride (ISO) Cannabichromene (ISO) cannabidiol (ISO) cannabigerol (ISO) Cannabinol (ISO) carbon nanotube (ISO) ciguatoxin CTX1B (ISO) cilnidipine (ISO) cimetidine (ISO) clofibrate (EXP) clozapine (ISO) cocaine (ISO) copper(II) sulfate (ISO) cyclosporin A (ISO) danazol (ISO) Delapril hydrochloride (ISO) delta8-THC (ISO) dextran sulfate (ISO) diarsenic trioxide (ISO) diethyl malate (ISO) difenoconazole (ISO) doxorubicin (ISO) Ebastine (ISO) efonidipine hydrochloride (ISO) endosulfan (EXP) epoxiconazole (ISO) ethanol (ISO) felodipine (ISO) fenofibrate (ISO) fluconazole (ISO) flutamide (EXP) gemfibrozil (ISO) glabridin (ISO) glafenine (EXP) glutathione (ISO) graphite (EXP) ketoconazole (ISO) L-ethionine (EXP) manidipine (ISO) menadione (ISO) mercaptopurine (EXP) methapyrilene (EXP) methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate (ISO) metyrapone (ISO) Muraglitazar (EXP) N-desmethylclozapine (ISO) N-methyl-N-nitrosourea (EXP) NADP zwitterion (ISO) NADP(+) (ISO) nicardipine (ISO) nifedipine (ISO) Nilvadipine (ISO) nisoldipine (ISO) nitrendipine (ISO) ochratoxin A (EXP) okadaic acid (ISO) omeprazole (EXP) oxycodone (EXP) ozone (ISO) paclitaxel (ISO) paracetamol (EXP,ISO) paraquat (ISO) pentanal (ISO) perfluorooctane-1-sulfonic acid (EXP) perfluorooctanoic acid (EXP,ISO) piperonyl butoxide (EXP) pirinixic acid (EXP,ISO) pomalidomide (ISO) pravastatin (EXP) prochloraz (ISO) propanal (ISO) propiconazole (EXP) purine-6-thiol (EXP) quercetin (ISO) quinapril hydrochloride (ISO) rifampicin (ISO) rotenone (EXP) rottlerin (ISO) Salvianolic acid A (ISO) Salvianolic acid C (ISO) sodium arsenite (ISO) streptozocin (EXP) sulindac (EXP) telmisartan (ISO) Terfenadine (ISO) Tesaglitazar (EXP) tetrachloromethane (ISO) tetracycline (ISO) tetraphene (ISO) thioacetamide (EXP) titanium dioxide (ISO) tranylcypromine (ISO) triadimefon (EXP,ISO) trichloroethene (EXP) triclosan (EXP) trimellitic anhydride (ISO) triphenyl phosphate (EXP) troglitazone (EXP,ISO) urethane (ISO) valproic acid (ISO) vinclozolin (EXP) zaragozic acid A (EXP)
Molecular Function
arachidonate 11,12-epoxygenase activity (ISO) arachidonate 14,15-epoxygenase activity (ISO) arachidonate epoxygenase activity (IEA,ISO) arachidonate monooxygenase activity (IDA) heme binding (IBA,IEA) iron ion binding (IEA) isomerase activity (ISO) linoleic acid epoxygenase activity (ISO) metal ion binding (IEA) monooxygenase activity (IEA) NADPH-hemoprotein reductase activity (IDA) oxidoreductase activity (IEA) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (IEA) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen (IBA,IEA)
1.
Macrophage epoxygenase determines a profibrotic transcriptome signature.
Behmoaras J, etal., J Immunol. 2015 May 15;194(10):4705-16. doi: 10.4049/jimmunol.1402979. Epub 2015 Apr 3.
2.
Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice.
Chen G, etal., Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):63-71. doi: 10.1016/j.prostaglandins.2011.06.009. Epub 2011 Jun 30.
3.
Differential expression of cytochrome P450 isoforms in the lungs of septic animals.
Cui X, etal., Crit Care Med. 2004 May;32(5):1186-91.
4.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
5.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
6.
Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia.
Herse F, etal., Circulation. 2012 Dec 18;126(25):2990-9. doi: 10.1161/CIRCULATIONAHA.112.127340. Epub 2012 Nov 15.
7.
Epoxyeicosatrienoic Acid inhibition alters renal hemodynamics during pregnancy.
Huang H, etal., Exp Biol Med (Maywood). 2006 Dec;231(11):1744-52.
8.
KEGG: Kyoto Encyclopedia of Genes and Genomes
KEGG
9.
Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.
Lee CR, etal., FASEB J. 2010 Oct;24(10):3770-81. doi: 10.1096/fj.10-160119. Epub 2010 May 21.
10.
CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study.
Lee CR, etal., Pharmacogenet Genomics. 2007 May;17(5):349-58.
11.
Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.
Liu PY, etal., Atherosclerosis. 2006 Nov 24;.
12.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
13.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
14.
Epoxygenase inactivation exacerbates diet and aging-associated metabolic dysfunction resulting from impaired adipogenesis.
Olona A, etal., Mol Metab. 2018 May;11:18-32. doi: 10.1016/j.molmet.2018.03.003. Epub 2018 Mar 9.
15.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
16.
SMPDB Annotation Import Pipeline
Pipeline to import SMPDB annotations from SMPDB into RGD
17.
GOA pipeline
RGD automated data pipeline
18.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
19.
Evidence for Association of Polymorphisms in CYP2J2 and Susceptibility to Essential Hypertension.
Wu SN, etal., Ann Hum Genet. 2007 Jul;71(Pt 4):519-25. Epub 2007 Feb 5.
20.
Overexpression of cytochrome P450 epoxygenases prevents development of hypertension in spontaneously hypertensive rats by enhancing atrial natriuretic peptide.
Xiao B, etal., J Pharmacol Exp Ther. 2010 Sep 1;334(3):784-94. doi: 10.1124/jpet.110.167510. Epub 2010 May 25.
21.
Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia.
Yaghi A, etal., Am J Physiol Lung Cell Mol Physiol 2003 Nov;285(5):L1099-105. Epub 2003 Jul 25.
22.
Excess nitric oxide decreases cytochrome P-450 2J4 content and P-450-dependent arachidonic acid metabolism in lungs of rats with acute pneumonia.
Yaghi A, etal., Am J Physiol Lung Cell Mol Physiol. 2004 Jun;286(6):L1260-7. Epub 2004 Feb 6.
23.
Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney.
Yu Z, etal., Mol Pharmacol. 2000 May;57(5):1011-20.
24.
CDNA cloning, heterologous expression, and characterization of rat intestinal CYP2J4.
Zhang QY, etal., Arch Biochem Biophys 1997 Apr 15;340(2):270-8.
25.
Characterization of the cytochrome P450 CYP2J4: expression in rat small intestine and role in retinoic acid biotransformation from retinal.
Zhang QY, etal., Arch Biochem Biophys. 1998 May 15;353(2):257-64.
26.
Induction of rat small intestinal cytochrome P-450 2J4.
Zhang QY, etal., Drug Metab Dispos. 1999 Oct;27(10):1123-7.
27.
Delivery of AAV2-CYP2J2 protects remnant kidney in the 5/6-nephrectomized rat via inhibition of apoptosis and fibrosis.
Zhao G, etal., Hum Gene Ther. 2012 Jul;23(7):688-99. doi: 10.1089/hum.2011.135. Epub 2012 Mar 29.
28.
Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats.
Zheng C, etal., Am J Respir Cell Mol Biol. 2010 Dec;43(6):740-9. doi: 10.1165/rcmb.2009-0161OC. Epub 2010 Jan 29.
Cyp2j4 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 116,295,691 - 116,323,219 (-) NCBI GRCr8 mRatBN7.2 5 111,179,981 - 111,207,490 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 111,178,703 - 111,244,794 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 113,748,215 - 113,775,559 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 115,473,589 - 115,500,933 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 115,536,117 - 115,563,461 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 119,546,458 - 119,564,843 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 119,546,461 - 119,564,846 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 119,130,644 - 119,130,903 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 Rnor_5.0 5 123,437,429 - 123,455,814 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 116,702,370 - 116,729,722 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 5 116,707,598 - 116,734,948 (-) NCBI Celera 5 109,770,343 - 109,797,690 (-) NCBI Celera Cytogenetic Map 5 q33 NCBI
CYP2J2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 59,893,308 - 59,969,212 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 59,893,308 - 59,926,773 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 60,358,980 - 60,392,445 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 60,131,568 - 60,165,011 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 60,071,001 - 60,104,444 NCBI Celera 1 58,647,783 - 58,681,160 (-) NCBI Celera Cytogenetic Map 1 p32.1 NCBI HuRef 1 58,469,963 - 58,503,340 (-) NCBI HuRef CHM1_1 1 60,474,448 - 60,507,891 (-) NCBI CHM1_1 T2T-CHM13v2.0 1 59,771,763 - 59,847,665 (-) NCBI T2T-CHM13v2.0
Cyp2j9 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 4 96,456,661 - 96,480,748 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 4 96,456,666 - 96,479,815 (-) Ensembl GRCm39 Ensembl GRCm38 4 96,568,424 - 96,592,523 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 4 96,568,429 - 96,591,578 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 4 96,235,120 - 96,258,176 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 4 96,060,447 - 96,083,503 (-) NCBI MGSCv36 mm8 Celera 4 94,937,695 - 94,960,750 (-) NCBI Celera Cytogenetic Map 4 C5 NCBI cM Map 4 44.66 NCBI
CYP2J2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 166,925,746 - 166,962,880 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 166,076,935 - 166,110,477 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 59,151,079 - 59,184,625 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 60,856,269 - 60,899,562 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 60,856,269 - 60,889,810 (-) Ensembl panpan1.1 panPan2
CYP2J2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 5 49,942,241 - 49,986,603 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 5 49,942,193 - 49,984,617 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 5 50,009,133 - 50,053,501 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 5 50,122,223 - 50,166,600 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 5 50,122,301 - 50,223,602 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 5 50,073,683 - 50,118,028 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 5 50,019,070 - 50,063,225 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 5 50,301,607 - 50,345,982 (+) NCBI UU_Cfam_GSD_1.0
LOC110261221 (Sus scrofa - pig)
CYP2J2 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 20 73,083,312 - 73,115,174 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 20 73,083,389 - 73,115,077 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666033 44,276,757 - 44,308,738 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
.
Predicted Target Of
Count of predictions: 112 Count of miRNA genes: 92 Interacting mature miRNAs: 98 Transcripts: ENSRNOT00000012977 Prediction methods: Microtar, Miranda Result types: miRGate_prediction
1331796 Thshl2 Thyroid stimulating hormone level QTL 2 2.3 blood thyroid-stimulating hormone amount (VT:0005119) serum thyroid stimulating hormone level (CMO:0001248) 5 97059760 147465714 Rat 1549845 Scl44 Serum cholesterol level QTL 44 6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 40128307 148607290 Rat 70212 Niddm25 Non-insulin dependent diabetes mellitus QTL 25 3.54 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 5 1 131345958 Rat 1298070 Scl18 Serum cholesterol level QTL 18 3.7 blood LDL cholesterol amount (VT:0000181) calculated plasma low density lipoprotein cholesterol level (CMO:0001245) 5 79584860 124584860 Rat 634305 Mamtr1 Mammary tumor resistance QTL 1 0.0001 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 12789751 113558310 Rat 61452 Ciaa5 CIA Autoantibody QTL 5 3.5 blood autoantibody amount (VT:0003725) calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281) 5 94858972 143070159 Rat 1331801 Rf33 Renal function QTL 33 4.149 kidney blood vessel physiology trait (VT:0100012) absolute change in renal vascular resistance (CMO:0001900) 5 43726656 129132602 Rat 7411582 Foco3 Food consumption QTL 3 7.5 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 5 87468046 132468046 Rat 61393 Bp7 Blood pressure QTL 7 4.5 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 60293434 161481680 Rat 1598859 Cm66 Cardiac mass QTL 66 2 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 79584860 124584860 Rat 7207486 Bss109 Bone structure and strength QTL 109 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 5 106906205 151906205 Rat 7207481 Bss106 Bone structure and strength QTL 106 7.9 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 5 106906205 151906205 Rat 1302790 Scl20 Serum cholesterol level QTL 20 6.4 0.0001 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 82394392 166664054 Rat 1578766 Tcas11 Tongue tumor susceptibility QTL 11 4.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 5 46711509 161317411 Rat 1549838 Bss4 Bone structure and strength QTL 4 9.2 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 5 106906205 151906205 Rat 2317753 Glom24 Glomerulus QTL 24 3.1 kidney glomerulus integrity trait (VT:0010546) kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269) 5 97570330 136479578 Rat 1582212 Livw2 Liver weight QTL 2 3.5 0.0004 liver mass (VT:0003402) liver weight to body weight ratio (CMO:0000633) 5 99016066 119085810 Rat 7411564 Bw135 Body weight QTL 135 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 87468046 132468046 Rat 8657050 Bw146 Body weight QTL 146 19.84 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 108938288 153938288 Rat 1576312 Emca8 Estrogen-induced mammary cancer QTL 8 4.1 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 50328551 141643988 Rat 7411601 Foco12 Food consumption QTL 12 19.7 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 5 87468046 132468046 Rat 1641912 Alcrsp18 Alcohol response QTL 18 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 5 35189153 141643988 Rat 1576314 Eutr1 Estrogen induced uterine response QTL 1 uterus integrity trait (VT:0010575) pyometritis severity score (CMO:0002009) 5 2138965 166875058 Rat 2317056 Wbc3 White blood cell count QTL 3 2.51 0.01 leukocyte quantity (VT:0000217) white blood cell count (CMO:0000027) 5 105999803 150999803 Rat 7394708 Emca11 Estrogen-induced mammary cancer QTL 11 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 99753548 113061097 Rat 1598846 Bp293 Blood pressure QTL 293 3.9 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 79584860 124584860 Rat 1598847 Cm62 Cardiac mass QTL 62 3.4 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 108845856 153845856 Rat 1358909 Kidm25 Kidney mass QTL 25 1.87 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 5 90067849 128034027 Rat 1578673 Bmd13 Bone mineral density QTL 13 4.9 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 5 103689353 148689353 Rat 70189 Mcs5 Mammary carcinoma susceptibility QTL 5 10.51 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 55805606 132207589 Rat 7207488 Bss110 Bone structure and strength QTL 1 8.4 femur strength trait (VT:0010010) femur stiffness (CMO:0001674) 5 106906205 151906205 Rat 631527 Tls1 T-lymphoma susceptibility QTL 1 0 0.001 thymus integrity trait (VT:0010555) post-insult time to onset of T-cell lymphoma (CMO:0001907) 5 90450144 135450144 Rat 7207491 Bss112 Bone structure and strength QTL 112 7 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 5 106906205 151906205 Rat 2290448 Scl54 Serum cholesterol level QTL 54 2.93 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 31663789 131345958 Rat 61426 Scl2 Serum cholesterol level QTL 2 7.3 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 59793399 143070159 Rat 1354598 Srn6 Serum renin concentration QTL 6 3.8 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 5 69540295 151018848 Rat 1298086 Bp156 Blood pressure QTL 156 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 84132602 129132602 Rat 2306971 Anxrr21 Anxiety related response QTL 21 9.47 fear/anxiety-related behavior trait (VT:1000241) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 5 66174080 124160948 Rat 1298089 Scl14 Serum cholesterol level QTL 14 5.8 0.0004 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 108845856 153845856 Rat 1358895 Bp254 Blood pressure QTL 254 3.6 0.0003 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 5 58829236 128034027 Rat 2316959 Gluco59 Glucose level QTL 59 4.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 5 34944474 113558310 Rat 6903316 Bw113 Body weight QTL 113 2 0.0103 body mass (VT:0001259) body weight (CMO:0000012) 5 87765973 132765973 Rat 1358889 Bp261 Blood pressure QTL 261 2.86 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 5 90067849 128034027 Rat 2316957 Pur21 Proteinuria QTL 21 6.2 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 5 59793528 113558156 Rat 1358187 Emca1 Estrogen-induced mammary cancer QTL 1 4.4 mammary gland integrity trait (VT:0010552) post-insult time to mammary tumor formation (CMO:0000345) 5 99216724 148607142 Rat
D5Got242
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 5 111,179,889 - 111,180,021 (+) MAPPER mRatBN7.2 Rnor_6.0 5 119,546,367 - 119,546,498 NCBI Rnor6.0 Rnor_5.0 5 123,437,338 - 123,437,469 UniSTS Rnor5.0 RGSC_v3.4 5 116,702,279 - 116,702,410 UniSTS RGSC3.4 Celera 5 109,770,252 - 109,770,383 UniSTS Cytogenetic Map 5 q33 UniSTS
This gene Cyp2j4 is modified in the following models/strains:
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000012503 ⟹ ENSRNOP00000012503
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 111,178,703 - 111,244,794 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000012977 ⟹ ENSRNOP00000012977
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 111,179,984 - 111,207,332 (-) Ensembl Rnor_6.0 Ensembl 5 119,546,461 - 119,564,846 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000058163 ⟹ ENSRNOP00000054968
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 111,220,049 - 111,244,789 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000079786 ⟹ ENSRNOP00000074827
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 111,179,984 - 111,198,902 (-) Ensembl
RefSeq Acc Id:
NM_023025 ⟹ NP_075414
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 116,295,691 - 116,323,042 (-) NCBI mRatBN7.2 5 111,179,981 - 111,207,332 (-) NCBI Rnor_6.0 5 119,546,458 - 119,564,843 (-) NCBI Rnor_5.0 5 119,130,644 - 119,130,903 (-) NCBI Rnor_5.0 5 123,437,429 - 123,455,814 (-) NCBI RGSC_v3.4 5 116,702,370 - 116,729,722 (-) RGD Celera 5 109,770,343 - 109,797,690 (-) RGD
Sequence:
CAGCTCGGACCTTCATTCCACAAAAGAACCAGCTCCAGTCCTAGCCATGCTCGCCACCGCGGGCTCTCTGGTAGCCACGATCTGGGCAGCGCTCCATCTCAGGACTCTGCTGGTGGCTGCACTCACCT TCCTACTCCTGGCTGACTACTTCAAAACCCGGCGCCCCAAGAACTATCCCCCGGGGCCTTGGGGTCTCCCATTCGTGGGCAACATATTCCAGTTGGACTTTGGGCAGCCCCACCTCTCAATCCAGCCG TTTGTGAAGAAATATGGGAATATTTTTAGCCTGAATCTTGGTGACATAACATCCGTGGTCATAACTGGACTGCCCTTAATCAAAGAAACCTTTACTCACATAGAACAAAACATTTTGAATCGCCCTCT CAGTGTTATGCAAGAACGCATCACCAATAAAAATGGATTGATCTTCTCCAGTGGTCAGACATGGAAGGAGCAAAGAAGGTTTGCCCTGATGACACTCAGGAATTTTGGCTTGGGAAAGAAGAGCTTAG AGCAGCGCATGCAGGAGGAGGCCCACTACCTCGTGGAAGCCATAAGAGAGGAGAAAGGAAAACCTTTCAACCCTCACTTCAGTATCAACAATGCAGTTTCCAATATCATTTGCTCTGTCACCTTTGGG GAGCGCTTTGAGTACCATGACAGTAGATTTCAGGAGATGCTGAGGTTGCTGGATGAGGTCATGTATTTGGAGACAACAATGATAAGCCAGCTCTATAATATTTTTCCATGGATAATGAAGTATATTCC TGGATCACATCAAACAGTTTTCAGAAACTGGGAAAAACTGAAATTGTTTGTCTCTTCTATGATCGATGATCACCGGAAAGACTGGAACCCTGAGGAGCCAAGAGACTTCATTGATGCTTTCCTCAAGG AAATGTCAAAGTACCCAGAGAAGACTACAAGTTTCAATGAAGAAAACCTCATCTGCAGCACCCTGGACCTCTTCTTTGCGGGAACAGAGACAACATCCACTACACTGCGCTGGGCTCTGCTCTACATG GCCCTCTACGCAGAAGTGCAAGAAAAAGTACAGGCAGAGATTGACAGAGTCATTGGCCAGAAGAGGGCAGCAAGCCTGGCCGATCGAGAATCCATGCCCTATACCAATGCCGTCATCCATGAGGTGCA GAGGATGGGCAACATCATCCCCCTGAATGTTCCCAGGGAAGTAGCAATGGATACCACTTTGAATGGATTCCACCTGCCAAAGGGTACCATGGTTCTAACCAACCTAACTGCACTGCACAGGGACCCAA AAGAGTGGGCCACCCCAGATGTGTTCAACCCAGAGCACTTTTTGGAGAATGGACAGTTTAAGAAGAGAGAATCTTTTCTGCCATTCTCAATGGGAAAGAGAGCTTGCCTTGGAGAACAACTGGCCAGG TCTGAACTGTTCATTTTCTTCACTTCTCTTATGCAAAAATTTACCTTCAAGCCCCCAACCAATGAGAAGCTGAGCCTGAAGTTCAGAAATGGCCTCACACTTTCTCCAGTCACGCACCGCATCTGTGC TGTCCCTAGAGAATGATGCTGGAGAAGCAAAGAGAAAAAGGAAGATGTGGTGTATGCCCTGAAGCATCTGGGCTTGCTCAAGTGAGAGGAGAAGGTGTTACGGAATGAATGTGATTCGAGCAATATTG AAGAAATTTGACTTAGAAAATTGAAGCAAACTCCTAGAATGATGGCCTCTTGATTTGGTGGTGGGCACATCACTTATGAGCTCAGTGGCGTGCCTTTGCATCTAAAAGTTAGGAGGACAATGGTGATT CTTCCTATAAACAAGGTGGATTAGTGAATTTAAAATGAATTAAACATCAAAATTAAAACTATAATTATTATTTTAAAAGTAAACTTTCTAAGTTCATCATGAATCGTATCTTGATTGGTGTATCATCA GTTTGCCTCCTTCCACCTTTCATACACTTGTATCTGGAACATTGATGTGTTGGCCTACAGCAGTGCAAGAAGAGAATAAGAATCAGAACTGAGCTGTGATTGCATCCACAGAAATGGGCTATTGAGAC TCCCAGATGACAGATCTGTCACTAGCTTCAGTAGATCTACATCCAAATTGATCTGGAAACCAGCAGAGCAGGGATCTTTCCCAACTCAGAGGCATGCAAAACAAATGATATAAAATCAATTACCTAGT TTTTAATTTTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_039110733 ⟹ XP_038966661
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 116,296,399 - 116,323,219 (-) NCBI mRatBN7.2 5 111,180,689 - 111,207,490 (-) NCBI
RefSeq Acc Id:
NP_075414 ⟸ NM_023025
- UniProtKB:
Q9QXF7 (UniProtKB/Swiss-Prot), Q5BKA2 (UniProtKB/TrEMBL), F7FF10 (UniProtKB/TrEMBL), A0A9K3Y868 (UniProtKB/TrEMBL)
- Sequence:
MLATAGSLVATIWAALHLRTLLVAALTFLLLADYFKTRRPKNYPPGPWGLPFVGNIFQLDFGQPHLSIQPFVKKYGNIFSLNLGDITSVVITGLPLIKETFTHIEQNILNRPLSVMQERITNKNGLIF SSGQTWKEQRRFALMTLRNFGLGKKSLEQRMQEEAHYLVEAIREEKGKPFNPHFSINNAVSNIICSVTFGERFEYHDSRFQEMLRLLDEVMYLETTMISQLYNIFPWIMKYIPGSHQTVFRNWEKLKL FVSSMIDDHRKDWNPEEPRDFIDAFLKEMSKYPEKTTSFNEENLICSTLDLFFAGTETTSTTLRWALLYMALYAEVQEKVQAEIDRVIGQKRAASLADRESMPYTNAVIHEVQRMGNIIPLNVPREVA MDTTLNGFHLPKGTMVLTNLTALHRDPKEWATPDVFNPEHFLENGQFKKRESFLPFSMGKRACLGEQLARSELFIFFTSLMQKFTFKPPTNEKLSLKFRNGLTLSPVTHRICAVPRE
hide sequence
Ensembl Acc Id:
ENSRNOP00000012977 ⟸ ENSRNOT00000012977
RefSeq Acc Id:
XP_038966661 ⟸ XM_039110733
- Peptide Label:
isoform X1
Ensembl Acc Id:
ENSRNOP00000054968 ⟸ ENSRNOT00000058163
Ensembl Acc Id:
ENSRNOP00000012503 ⟸ ENSRNOT00000012503
Ensembl Acc Id:
ENSRNOP00000074827 ⟸ ENSRNOT00000079786
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2010-04-19
Cyp2j4
cytochrome P450, family 2, subfamily j, polypeptide 4
Cyp2j4
cytochrome P450, family 2, subfamily J, polypeptide 4
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2004-12-02
Cdk5rap3
cytochrome P450, family 2, subfamily J, polypeptide 4
Cyp2j4
CYP2J4
Name updated
1299863
APPROVED
2002-08-07
Cyp2j4
CYP2J4
Symbol and Name status set to provisional
70820
PROVISIONAL
Note Type
Note
Reference
gene_disease
may be involved with rat model of acute Pseudomonas pneumonia
1299258
gene_expression
expressed in liver, intestine, olfactory mucosa, kidney, heart, and lung
632631
gene_homology
72.5 and 75.8% amino acid identity to rabbit and human, respectively
632631
gene_protein
501 amino acids
632631